跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
GS-1
首页
药物
GS-1
GS-1
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
CHO EXPRESSION SYSTEM
US 2015140607 A1
申请人: SANOFI SA
优先权: 2012
CN
EP
US
5 件公开
Organic Compound, Charge-Transporting Material, and Organic Electroluminescent Element
US 2008145699 A1
申请人: PIONEER CORP
优先权: 2004
CN
EP
US
4 件公开
Therapeutically useful synthetic oligonucleotides
US 7157436 B2
申请人: BIONICHE LIFE SCIENCES INC
优先权: 1999
CN
US
4 件公开
Catalyst comprising cyclic acylurea compounds and processes for production organic compounds with the same
US 7091342 B2
申请人: DAICEL CHEM
优先权: 2001
US
4 件公开
Compositions and methods for combination antiviral therapy
US 2006234982 A1
申请人: DAHL TERRENCE C
优先权: 2003
CN
US
3 件公开
Modulation of Fas and FasL expression
US 7662792 B2
申请人: BIONICHE LIFE SCIENCES INC
优先权: 2001
US
3 件公开
WO 0218593 A3
申请人: BIONICHE LIFE SCIENCES INC
优先权: 2000
WO
Combination products for the treatment of RSV
US 10363253 B2
申请人: JANSSEN SCIENCES IRELAND UNLIMITED CO
优先权: 2016
EP
US
2 件公开
ISCHEMIA-REPERFUSION INJURY INHIBITOR
EP 4582094 A1
申请人: UNIV TOHOKU
优先权: 2022
EP
WO
2 件公开
SUSTAINED-RELEASE PLGA MICROSPHERE CONTAINING GS-441524, AND METHOD FOR PRODUCING SAME
US 20260165968 A1
申请人: IAC IN NAT UNIV CHUNGNAM
优先权: 2022
US
WO
2 件公开
KIM-1 ACTIVE TARGETING GOLD NANOPARTICLES, PREPARATION METHOD AND APPLICATION THEREOF
US 20260199530 A1
申请人: GUANGZHOU FIRST PEOPLES HOSPITAL
优先权: 2025
CN
US
2 件公开
第 1 / 6 页
上一页
下一页
药物
反馈